Reuters logo
22 天内
BRIEF-Myovant Sciences initiates phase 3 clinical program of relugolix
2017年6月29日 / 上午11点17分 / 22 天内

BRIEF-Myovant Sciences initiates phase 3 clinical program of relugolix

1 分钟阅读

June 29 (Reuters) - Myovant Sciences Ltd

* Myovant sciences ltd - initiates phase 3 clinical program of relugolix in women with endometriosis-associated pain Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below